atai Life Sciences to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Conference | Psychedelic Invest

NEW YORK and BERLIN, May 23, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the appointment of Scott Braunstein, M.D., and Laurent Fischer, M.D., as independent directors of atai’s supervisory board (“Board”) subject to applicable legal requirements. Scott…

Pfizer, Idorsia and AbbVie drug brands lead the way in pharma digital marketing — study

What do popular Stanley insulated cups have in common with two pharma migraine brands? They’re all transformational digital brands, according to new research out this

December 2, 2023

Pharmalittle: We’re reading about FDA commish’s parting thoughts, a warning on RSV shots, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After

January 8, 2025

Innovative robotic lung transplant performed at NYU Langone Health

Surgeons at NYU Langone Health performed the first fully robotic lung transplant in the nation. The procedure marks a new milestone in surgical innovation and

September 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.